178 related articles for article (PubMed ID: 31091284)
1. Circulating sphingosine-1-phosphate as a prognostic biomarker for community-acquired pneumonia.
Hsu SC; Chang JH; Hsu YP; Bai KJ; Huang SK; Hsu CW
PLoS One; 2019; 14(5):e0216963. PubMed ID: 31091284
[TBL] [Abstract][Full Text] [Related]
2. Sphingosine-1-phosphate as an indicator for deciding the use of adjuvant corticosteroids therapy in community-acquired pneumonia (sphingosine-1-phosphate and pneumonia trial): Study protocol for a randomized, placebo-controlled trial.
Hsu SC; Huang WC; Liu CT; Hsu YP; Chang JH; Huang SK; Hsu CW
Medicine (Baltimore); 2019 Sep; 98(38):e17278. PubMed ID: 31568009
[TBL] [Abstract][Full Text] [Related]
3. Sphingosine-1-phosphate and CRP as potential combination biomarkers in discrimination of COPD with community-acquired pneumonia and acute exacerbation of COPD.
Hsu CW; Suk CW; Hsu YP; Chang JH; Liu CT; Huang SK; Hsu SC
Respir Res; 2022 Mar; 23(1):63. PubMed ID: 35307030
[TBL] [Abstract][Full Text] [Related]
4. Decreased serum level of sphingosine-1-phosphate: a novel predictor of clinical severity in COVID-19.
Marfia G; Navone S; Guarnaccia L; Campanella R; Mondoni M; Locatelli M; Barassi A; Fontana L; Palumbo F; Garzia E; Ciniglio Appiani G; Chiumello D; Miozzo M; Centanni S; Riboni L
EMBO Mol Med; 2021 Jan; 13(1):e13424. PubMed ID: 33190411
[TBL] [Abstract][Full Text] [Related]
5. Prognostic performance of MR-pro-adrenomedullin in patients with community acquired pneumonia in the Emergency Department compared to clinical severity scores PSI and CURB.
Legramante JM; Mastropasqua M; Susi B; Porzio O; Mazza M; Miranda Agrippino G; D Agostini C; Brandi A; Giovagnoli G; Di Lecce VN; Bernardini S; Minieri M
PLoS One; 2017; 12(11):e0187702. PubMed ID: 29161297
[TBL] [Abstract][Full Text] [Related]
6. Inverse Correlation Between Plasma Sphingosine-1-Phosphate and Ceramide Concentrations in Septic Patients and Their Utility in Predicting Mortality.
Wu X; Hou J; Li H; Xie G; Zhang X; Zheng J; Wang J; Gao F; Yao Y; Liu H; Fang X
Shock; 2019 Jun; 51(6):718-724. PubMed ID: 30080743
[TBL] [Abstract][Full Text] [Related]
7. Dynamics of Vascular Protective and Immune Supportive Sphingosine-1-Phosphate During Cardiac Surgery.
Greiwe G; Moritz E; Amschler K; Poppe A; Sarwari H; Nierhaus A; Kluge S; Reichenspurner H; Zoellner C; Schwedhelm E; Daum G; Tampe B; Winkler MS
Front Immunol; 2021; 12():761475. PubMed ID: 34745137
[TBL] [Abstract][Full Text] [Related]
8. Reliability of Pro-adrenomedullin and Interleukin 1β in Predicting Severity of Community-Acquired Pneumonia in Pediatric Patients.
Korkmaz MF; Güzel A; Açıkgöz M; Okuyucu A; Alaçam H
Ann Clin Lab Sci; 2018 Jan; 48(1):81-89. PubMed ID: 29531001
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine as a prognostic marker in community-acquired pneumonia requiring hospitalization: a pilot study.
Cho WH; Yeo HJ; Yoon SH; Lee SE; Jeon DS; Kim YS; Lee SJ; Jo EJ; Mok JH; Kim MH; Kim KU; Lee K; Park HK; Lee MK
Eur J Clin Microbiol Infect Dis; 2015 Feb; 34(2):309-15. PubMed ID: 25172637
[TBL] [Abstract][Full Text] [Related]
10. Serum 8-Hydroxydeoxyguanosine Is a Potential Indicator for the Severity and Prognosis in Patients with Community-Acquired Pneumonia: A Prospective Cohort Study.
Cao LF; Cheng JY; Xu Z; Feng CM; Zhao H; Wang XM; Fu L
J Immunol; 2022 Jan; 208(2):321-327. PubMed ID: 34911771
[TBL] [Abstract][Full Text] [Related]
11. U-shaped association between plasma sphingosine-1-phosphate levels and mortality in patients with chronic systolic heart failure: a prospective cohort study.
Xue Y; Jiang W; Ma Q; Wang X; Jia P; Li Q; Chen S; Song B; Wang Y; Zhang J; Liu J; Yang G; Lin Y; Liu J; Wei L; Dong C; Li H; Xie Z; Bai L; Ma A
Lipids Health Dis; 2020 Jun; 19(1):125. PubMed ID: 32498720
[TBL] [Abstract][Full Text] [Related]
12. The relationship between the high-density lipoprotein (HDL)-associated sphingosine-1-phosphate (S1P) and coronary in-stent restenosis.
Jing XD; Wei XM; Deng SB; Du JL; Liu YJ; She Q
Clin Chim Acta; 2015 Jun; 446():248-52. PubMed ID: 25958848
[TBL] [Abstract][Full Text] [Related]
13. Low sphingosine-1-phosphate plasma levels are predictive for increased mortality in patients with liver cirrhosis.
Becker S; Kinny-Köster B; Bartels M; Scholz M; Seehofer D; Berg T; Engelmann C; Thiery J; Ceglarek U; Kaiser T
PLoS One; 2017; 12(3):e0174424. PubMed ID: 28334008
[TBL] [Abstract][Full Text] [Related]
14. Serum Sphingosine-1-phosphate level and peritonitis in peritoneal dialysis patients.
Bai Q; Guo HX; Su CY; Han QF; Wang T; Tang W
Ren Fail; 2020 Nov; 42(1):829-835. PubMed ID: 32787649
[TBL] [Abstract][Full Text] [Related]
15. Serum S1P level in interstitial lung disease (ILD) is a potential biomarker reflecting the severity of pulmonary function.
Ding F; Wang Z; Wang J; Ma Y; Jin J
BMC Pulm Med; 2024 Jun; 24(1):266. PubMed ID: 38835000
[TBL] [Abstract][Full Text] [Related]
16. Decreased serum concentrations of sphingosine-1-phosphate in sepsis.
Winkler MS; Nierhaus A; Holzmann M; Mudersbach E; Bauer A; Robbe L; Zahrte C; Geffken M; Peine S; Schwedhelm E; Daum G; Kluge S; Zoellner C
Crit Care; 2015 Oct; 19():372. PubMed ID: 26498205
[TBL] [Abstract][Full Text] [Related]
17. Plasma kallistatin levels in patients with severe community-acquired pneumonia.
Lin WC; Lu SL; Lin CF; Chen CW; Chao L; Chao J; Lin YS
Crit Care; 2013 Feb; 17(1):R27. PubMed ID: 23394256
[TBL] [Abstract][Full Text] [Related]
18. Usefulness of midregional proadrenomedullin to predict poor outcome in patients with community acquired pneumonia.
Gordo-Remartínez S; Calderón-Moreno M; Fernández-Herranz J; Castuera-Gil A; Gallego-Alonso-Colmenares M; Puertas-López C; Nuevo-González JA; Sánchez-Sendín D; García-Gámiz M; Sevillano-Fernández JA; Álvarez-Sala LA; Andueza-Lillo JA; de Miguel-Yanes JM
PLoS One; 2015; 10(6):e0125212. PubMed ID: 26030588
[TBL] [Abstract][Full Text] [Related]
19. YKL-40, CCL18 and SP-D predict mortality in patients hospitalized with community-acquired pneumonia.
Spoorenberg SM; Vestjens SM; Rijkers GT; Meek B; van Moorsel CH; Grutters JC; Bos WJ;
Respirology; 2017 Apr; 22(3):542-550. PubMed ID: 27782361
[TBL] [Abstract][Full Text] [Related]
20. A novel biochemical marker for community-acquired pneumonia: Ischemia-modified albumin.
Bolatkale M; Duger M; Ülfer G; Can Ç; Acara AC; Yiğitbaşı T; Seyhan EC; Bulut M
Am J Emerg Med; 2017 Aug; 35(8):1121-1125. PubMed ID: 28302374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
